Search

everythinglearnresearchcommunity

for

Search:↓

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

A male with aromatase deficiency improved bone health with estradiol treatment.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Some supplements and hormones can increase hair loss by raising DHT levels.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Different STUB1 gene mutations cause varied symptoms in autosomal recessive ataxias.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Too much androgen can cause hair loss; finasteride may help.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.